Patent · US Active

Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

US7795379B2 · kind B2 · utility

1Cited by

1References

23Claims

0Family size

Assignee

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Elke Jager · Frankfurt am Main, DE
Dirk Jager · New York, US
Alexander Knuth · Frankfurt am Main, DE

Key dates

Filing date	Sep 6, 2005
Grant date	Sep 14, 2010
Priority date	—
Expiry date	Aug 11, 2026

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/57484
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.